Casavola V, Iacovelli L, Svelto M
Pflugers Arch. 1987 Mar;408(3):318-20. doi: 10.1007/BF02181476.
Serosal preincubation of frog skin with tetradecanoyl phorbol acetate, TPA, an activator of protein kinase C, inhibits the hydrosmotic response elicited by vasopressin (AVP) but not that induced by 8br-cAMP. This proves that serosal TPA primarily influences a pre-cAMP step. The TPA-induced inhibition of AVP response appears to be related to TPA-induced prostaglandin synthesis. The pretreatment with naproxen, in fact, prevents the inhibition induced by serosal TPA on the AVP response. On the contrary, mucosal TPA produces a more marked inhibition of the response to AVP and significantly diminishes the water flow induced by 8br-cAMP; this suggests that mucosal TPA interferes mainly with a post-cAMP step. Furthermore, naproxen is unable to completely prevent the inhibition induced by mucosal TPA on AVP response thus indicating that mucosal TPA may also activate a prostaglandin-independent mechanism able to inhibit one of the last steps of the hydrosmotic response to AVP.
用蛋白激酶C激活剂十四酰佛波醇乙酸酯(TPA)对蛙皮进行浆膜预孵育,可抑制血管加压素(AVP)引发的渗透反应,但不抑制8-溴-cAMP诱导的反应。这证明浆膜TPA主要影响cAMP前的步骤。TPA诱导的对AVP反应的抑制似乎与TPA诱导的前列腺素合成有关。事实上,用萘普生预处理可防止浆膜TPA对AVP反应的抑制。相反,黏膜TPA对AVP反应产生更显著的抑制,并显著减少8-溴-cAMP诱导的水流量;这表明黏膜TPA主要干扰cAMP后的步骤。此外,萘普生无法完全阻止黏膜TPA对AVP反应的抑制,因此表明黏膜TPA也可能激活一种不依赖前列腺素的机制,该机制能够抑制对AVP渗透反应的最后步骤之一。